Both stromal and tumor ANXA1-expressing cells contribute to TME communication by autocrine, paracrine, and juxtacrine signaling pathways, stimulating tumor cell proliferation, disease progression, invasion, metastasis, and resistance to therapy [23,126,127]. The gene discussed is ANXA1; the disease is neoplasm.